PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+15.75%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.89B
AUM Growth
+$1.89B
(+15%)
Cap. Flow
-$4.11M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
39.85%
Holding
93
New
19
Increased
21
Reduced
14
Closed
17
Top Buys
| 1 |
Outset Medical
OM
|
$131M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$41.4M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$29.8M |
| 4 |
Avantor
AVTR
|
$28.6M |
| 5 |
Gilead Sciences
GILD
|
$25.6M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$156M |
| 2 |
McKesson
MCK
|
$50.5M |
| 3 |
Cardinal Health
CAH
|
$45.2M |
| 4 |
Labcorp
LH
|
$31.4M |
| 5 |
Baxter International
BAX
|
$25.4M |
Sector Composition
| 1 | Healthcare | 77.72% |
| 2 | Technology | 5.64% |
| 3 | Consumer Discretionary | 1.62% |
| 4 | Industrials | 0.9% |
| 5 | Utilities | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
26
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $26.2M | 1.21% |
1,294,977
+243,587
| +23% | +$4.94M |
|
|
AERI
27
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $26.2M | 1.21% |
2,227,611
-46,609
| -2% | -$549K |
|
28
Biogen
BIIB
$20.8B
| $25.5M | 1.18% |
+89,716
| New | +$25.5M |
|
29
Henry Schein
HSIC
$8.14B
| $23.6M | 1.09% |
+402,310
| New | +$23.6M |
|
30
Icon
ICLR
$14B
| $23.2M | 1.07% |
121,323
+18,357
| +18% | +$3.51M |
|
31
AstraZeneca
AZN
$255B
| $21.3M | 0.98% |
387,900
-247,700
| -39% | -$13.6M |
|
32
Tenet Healthcare
THC
$16.5B
| $20.6M | 0.95% |
841,194
+262,569
| +45% | +$6.44M |
|
33
Microsoft
MSFT
$3.76T
| $20M | 0.93% |
95,177
| – | – |
|
34
Revvity
RVTY
$9.68B
| $18.5M | 0.85% |
+147,000
| New | +$18.5M |
|
35
Hologic
HOLX
$14.7B
| $18.1M | 0.84% |
272,193
-341,583
| -56% | -$22.7M |
|
36
NXP Semiconductors
NXPI
$57.5B
| $18.1M | 0.84% |
144,881
+17,010
| +13% | +$2.12M |
|
37
Pfizer
PFE
$141B
| $17.6M | 0.81% |
+478,361
| New | +$17.6M |
|
38
Acadia Pharmaceuticals
ACAD
$4.34B
| $17.4M | 0.8% |
+421,087
| New | +$17.4M |
|
39
Deere & Co
DE
$127B
| $16.9M | 0.78% |
76,336
| – | – |
|
40
Amazon
AMZN
$2.41T
| $16.8M | 0.78% |
5,342
| – | – |
|
|
TRIL
41
DELISTED
Trillium Therapeutics Inc.
TRIL
| $16M | 0.74% |
1,126,325
+271,055
| +32% | +$3.85M |
|
|
TCRR
42
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $15.8M | 0.73% |
+775,794
| New | +$15.8M |
|
43
NVIDIA
NVDA
$4.15T
| $14M | 0.65% |
25,911
-12,202
| -32% | -$6.6M |
|
44
Aptiv
APTV
$17.3B
| $13.8M | 0.64% |
150,794
+13,037
| +9% | +$1.2M |
|
45
NextEra Energy, Inc.
NEE
$148B
| $13.1M | 0.61% |
47,151
+26,581
| +129% | +$7.38M |
|
46
Dynavax Technologies
DVAX
$1.19B
| $12.7M | 0.59% |
2,936,990
+1,793,464
| +157% | +$7.75M |
|
47
Iovance Biotherapeutics
IOVA
$800M
| $12.6M | 0.58% |
+381,990
| New | +$12.6M |
|
48
Revolution Medicines
RVMD
$7.43B
| $12.5M | 0.58% |
+360,313
| New | +$12.5M |
|
49
Avidity Biosciences
RNA
$6.12B
| $11M | 0.51% |
+441,155
| New | +$11M |
|
|
KRTX
50
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10.7M | 0.49% |
137,960
-214,585
| -61% | -$16.6M |
|